<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04653909</url>
  </required_header>
  <id_info>
    <org_study_id>2020/032</org_study_id>
    <nct_id>NCT04653909</nct_id>
  </id_info>
  <brief_title>The Physiotherapy and Rehabilitation in Calfan Syndrome</brief_title>
  <official_title>The Effectiveness of Rehabilitation Program in an Ultra-rare Calfan Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasan Kalyoncu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasan Kalyoncu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Calfan syndrome is a progressive neurodegenerative systemic disease. It is a rare and&#xD;
      difficult disease to diagnose due to the complex symptoms that occur over the years to&#xD;
      postpartum. The aim of this study is to investigate the effectiveness of the physiotherapy&#xD;
      and rehabilitation program in a rare case with Calfan syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      13 years old, a female patient was diagnosed with Calfan syndrome one year ago. Only 11&#xD;
      patients have been identified in the literature. Its phenotype is characterized by recurrent&#xD;
      episodes of liver failure and hepatic fibrosis in early childhood. Our patient had&#xD;
      neurological symptoms that were gait disturbances, ataxia and tremor, as well as peripheral&#xD;
      neuropathy and cognitive impairment. Also, musculoskeletal problems such as scoliosis, hip&#xD;
      dysplasia, osteoporosis, thoracic kyphosis, and increased lordosis were observed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">November 17, 2020</completion_date>
  <primary_completion_date type="Actual">October 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Case study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trunk Control</measure>
    <time_frame>3 month</time_frame>
    <description>The Trunk Disorder Scale (TIS) was used to assess static and dynamic sitting balance and trunk coordination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The severity of ataxia</measure>
    <time_frame>3 month</time_frame>
    <description>The International Ataxia Rating Scale (ICARS) was used to determine the severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The quality of life</measure>
    <time_frame>3 month</time_frame>
    <description>The Children's Quality of Life Scale (PedsQL) was used determine to quality of life level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Functional Independence</measure>
    <time_frame>3 month</time_frame>
    <description>The Functional Independence Scale for Children (WeeFIM) was used determine to independence level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper extremity functional performance</measure>
    <time_frame>3 month</time_frame>
    <description>The 9-Hole Peg test was used to evaluate upper extremity performance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper extremity disability level</measure>
    <time_frame>3 month</time_frame>
    <description>the Quick Questionnaire for Arm, Shoulder and Hand Problems (Q-DASH) scale was used to evaluate physical disability and symptoms of upper extremity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>CALFAN Syndrome</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A patient who was diagnosed with the calfan syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rehabilitation</intervention_name>
    <description>The abdominal and back strengthening exercises on the mat, the open-closed perturbation training in sitting and standing positions for trunk control. Functional exercises were performed in the same positions for simulating daily living activities. The stretching and strengthening exercises were applied to her scoliosis and also given trunk orthoses.</description>
    <arm_group_label>Case</arm_group_label>
    <other_name>Orthoses</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Calfan syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any surgery in past six months&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hasan Kalyoncu Üniversity</name>
      <address>
        <city>Gaziantep</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Spagnoli C, Frattini D, Salerno GG, Fusco C. On CALFAN syndrome: report of a patient with a novel variant in SCYL1 gene and recurrent respiratory failure. Genet Med. 2019 Jul;21(7):1663-1664. doi: 10.1038/s41436-018-0389-6. Epub 2018 Dec 10.</citation>
    <PMID>30531813</PMID>
  </reference>
  <reference>
    <citation>Lenz D, McClean P, Kansu A, Bonnen PE, Ranucci G, Thiel C, Straub BK, Harting I, Alhaddad B, Dimitrov B, Kotzaeridou U, Wenning D, Iorio R, Himes RW, Kuloğlu Z, Blakely EL, Taylor RW, Meitinger T, Kölker S, Prokisch H, Hoffmann GF, Haack TB, Staufner C. SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN). Genet Med. 2018 Oct;20(10):1255-1265. doi: 10.1038/gim.2017.260. Epub 2018 Feb 8.</citation>
    <PMID>29419818</PMID>
  </reference>
  <reference>
    <citation>Lenz D, Staufner C, Wächter S, Hagedorn M, Ebersold J, Göhring G, Kölker S, Hoffmann GF, Jung-Klawitter S. Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL1. Stem Cell Res. 2019 May;37:101428. doi: 10.1016/j.scr.2019.101428. Epub 2019 Mar 22.</citation>
    <PMID>30959346</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 26, 2020</study_first_submitted>
  <study_first_submitted_qc>December 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>December 3, 2020</last_update_submitted>
  <last_update_submitted_qc>December 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasan Kalyoncu University</investigator_affiliation>
    <investigator_full_name>Serkan Usgu</investigator_full_name>
    <investigator_title>Assistant of professeur</investigator_title>
  </responsible_party>
  <keyword>ataxia</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>disabilities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The applied rehabilitation protocol.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Five years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

